Jeffrey A. Bacha
8Patents
1h-index
10Co-inventors
40Inventor score
Filing activity: Jan 22, 2013 → Jan 8, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9687466B2 | Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiforme | Emerging Cross-Sectional Technologies | 4 | Active |
| US10201521B2 | Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma | Emerging Cross-Sectional Technologies | 1 | Active |
| US11541027B2 | Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases | Chemistry; Metallurgy | 0 | Active |
| US11717505B2 | Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas | Human Necessities | 0 | Active |
| US9814693B2 | Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies | Physics | 0 | Active |
| US11026914B2 | Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor | Human Necessities | 0 | Active |
| US11234955B2 | Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma | Emerging Cross-Sectional Technologies | 0 | Active |
| US11446274B2 | Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignancies | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.